Interesting, but of great concern with AVNR trading at this level. I could be wrong, but we may not want that to happen just yet, with the stock at only $2. Better for someone to look at this type of deal down the road, but we can't control that. I am confident that the Avanir Board will have enough of a sense of the long term value of Zenvia to not let it go for a song. Who knows? - Maybe Teva is thinking it is a bargain even up in double digits. Just some thoughts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.